Mr. Lampropouloscontinued: “We are confident in our team’s ability to deliver our financial guidance for fiscal year 2024, which we have updated to reflect the stronger-than-expected organic growth and profitability results to-date. Our updated guidance continues to assume the fore...
The inflationary impact is further exacerbated by continued clinical workforce shortages in 2023-24, prompting hospitals to increase salaries and consequently seek higher reimbursement from payers. On the pharmacy side, the introduction of new cell and gene therapies (11 approved in the past three ...
The Spanish Ministry of Health (“MoH”) is the department of the Government of Spain responsible for, among others, proposing and executing regulations and decisions on pricing and reimbursement of medicinal products that are financed with Spanish public funds. Considering that the reimbursement of m...
Same-unit revenue from net reimbursement-related factors increased by 3.4 percent for the 2024 third quarter as compared to the prior-year period. This increase primarily reflects improved payor mix and modest improvements in hospital contract administrative fees. The percentage of services reimbursed ...
However, these provisions may have the effect of discouraging lawsuits against our directors, officers, employees and agents as it may limit any stockholder's ability to bring a claim in a judicial forum that such stockholder finds favorable for disputes with us or our directors, officers, ...
7/25/2023 12/3/2024 Single insertion delivery system for treating embolism and associated systems and methods Vascular diseases, Hematology, Cardiology, Cardiac anatomy, Angiology Grant LatestInari MedicalNews Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, In...
1. Sharma et al. 2023. “Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus–Related Neoplasia in the United States.” Journal of Health Economics and Outcomes Research10, no. 1 ...
In 2023, Olympus Corporation acquired Taewoong Medical Co. Ltd., a Korean medical device manufacturer specializing in gastrointestinal (GI) metallic stents. This acquisition bolstered Olympus’s GI EndoTherapy product portfolio and improved its ability to provide comprehensive solutions for improved patien...
and growth and expansion of our operations, and the anticipated tax treatment of the merger; our ability to retain, attract and hire key personnel; potential adverse reactions or changes to relationships with employees, suppliers or other parties resulting from the completion of the merger; ...
- accurate reporting and billing for government and third-party reimbursement, including accurate and complete medical records to support such billing and, in the U.S., the obligation to report and return overpayments within 60 days of the time that the overpayment is identified and quantified;-...